Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVH Evolent Health

Post-Mkt 08-07 18:22:08 EDT

3.95

+0.36

+10.03%

盘后4.05

+0.10+2.52%

18:20 EDT

High4.13	Low3.61	Vol5.08M
Open3.70	D1 Closing3.59	Amplitude14.48%
Mkt Cap444.30M	Tradable Cap371.09M	Total Shares112.48M
T/O20.19M	T/O Rate5.41%	Tradable Shares93.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVH","market":"US","secType":"STK","nameCN":"Evolent Health","latestPrice":3.95,"timestamp":1786132800000,"preClose":3.59,"halted":0,"volume":5081779,"hourTrading":{"tag":"盘后","latestPrice":4.0497,"preClose":3.95,"latestTime":"18:20 EDT","volume":26228,"amount":103631.994916,"timestamp":1786141215663,"change":0.0997,"changeRate":0.025241,"amplitude":0.055367},"delay":0,"changeRate":0.10027855153203352,"floatShares":93946400,"shares":112481067,"eps":-4.708928,"marketStatus":"Post-Mkt","change":0.36,"latestTime":"08-07 18:22:08 EDT","open":3.7,"high":4.13,"low":3.61,"amount":20190453.2418867,"amplitude":0.144847,"askPrice":4.18,"askSize":100,"bidPrice":3.95,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-4.708928,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786147200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1433476800000,"exchange":"NYSE","adjPreClose":3.59,"preHourTrading":{"tag":"盘前","latestPrice":3.75,"preClose":3.59,"latestTime":"09:29 EDT","volume":3646,"amount":13525.050291,"timestamp":1786109399999,"change":0.16,"changeRate":0.044568,"amplitude":0.047354},"postHourTrading":{"tag":"盘后","latestPrice":4.0497,"preClose":3.95,"latestTime":"18:20 EDT","volume":26228,"amount":103631.994916,"timestamp":1786141215663,"change":0.0997,"changeRate":0.025241,"amplitude":0.055367},"volumeRatio":1.201921,"impliedVol":1.6751,"impliedVolPercentile":0.6972},"requestUrl":"/m/hq/s/EVH","defaultTab":"news","newsList":[{"id":"2657366133","title":"Evolent Health: Buy Rating Reiterated as Strong Contracts and Enhanced Risk Protections Support Growth; $5 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2657366133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657366133?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:35","pubTimestamp":1786055740,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Shea from Needham reiterated a Buy rating on Evolent Health, with a price target of $5.00. Matthew Shea has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/evolent-health-buy-rating-reiterated-as-strong-contracts-and-enhanced-risk-protections-support-growth-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/evolent-health-buy-rating-reiterated-as-strong-contracts-and-enhanced-risk-protections-support-growth-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657925668","title":"Progyny Q2 Revenue Rises 5%, Slightly Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657925668","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657925668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:31","pubTimestamp":1786048265,"startTime":"0","endTime":"0","summary":"Progyny Q2 revenue rises 5%, slightly beats estimatesOverviewWomen's health benefits provider's Q2 revenue rose 5%, slightly beating analyst expectationsQ2 adjusted EBITDA rose 7%, beating analyst exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","PRVA","BK4154","BK4167","BK4539","BK4581","BK4196","LU0053671581.USD","PGNY","EVH","HNGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657246659","title":"Evolent Health: Improving Fundamentals, Raised Long‑Term Guidance and Strong Contract Pipeline Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657246659","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657246659?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:35","pubTimestamp":1786037749,"startTime":"0","endTime":"0","summary":"William Blair analyst Ryan Daniels has reiterated their bullish stance on EVH stock, giving a Buy rating on July 28. Ryan Daniels has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/evolent-health-improving-fundamentals-raised-longterm-guidance-and-strong-contract-pipeline-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/evolent-health-improving-fundamentals-raised-longterm-guidance-and-strong-contract-pipeline-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657630548","title":"Evolent Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657630548","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657630548?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:16","pubTimestamp":1786025791,"startTime":"0","endTime":"0","summary":"Evolent Health, Inc. reports results for the quarter ended June 30 - Earnings SummaryEvolent Health, Inc.EVH.Nreported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N44328L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4167","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657335556","title":"Evolent Q2 2026 Earnings: Revenue Growth Came With Margin Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657335556","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657335556?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:17","pubTimestamp":1786015060,"startTime":"0","endTime":"0","summary":"Evolent Health’s (NYSE: EVH) Q2 2026 revenue rose 46.9% year over year to $652.5 million, while its GAAP diluted loss narrowed to $0.25 per share from $0.44. Performance Suite revenue increased 80.8%, but profitability weakened as the medical expense ratio climbed to 95.3% and adjusted EBITDA fell 25.3% to $28.1 million. Evolent raised full-year revenue guidance to $2.6 billion-$2.7 billion, tightened adjusted EBITDA guidance to $120 million-$135 million, and outlined a 2027 outlook supported by scheduled launches and oncology demand.","market":"sh","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262082979-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH","LU0053671581.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657163638","title":"Evolent Q2 FY26 Net Loss Narrows to $28.36 Million; Revenue Rises 46.84% to $652.52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657163638","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657163638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:07","pubTimestamp":1786014473,"startTime":"0","endTime":"0","summary":"Evolent Q2 FY26 net loss narrows to $28.36 million; revenue rises 46.84% to $652.52 millionEvolent Health posted Q2 2026 revenue of USD 652.52 million, up 46.85% from a year earlier; net loss narrowed","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL6cNqGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH","BK4167","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684638","title":"Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684638","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:05","pubTimestamp":1786014310,"startTime":"0","endTime":"0","summary":"Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 120 percent increase over losses of $(0.10) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60987410/evolent-health-q2-adj-eps-0-02-beats-0-02-estimate-sales-652-520m-beat-597-997m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657388156","title":"Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657388156","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657388156?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:01","pubTimestamp":1786014066,"startTime":"0","endTime":"0","summary":"BRIEF-Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 MillionAug 06 (Reuters) - Evolent Health Q2 adjusted EBITDA USD 28.05 million.Q2 adjusted EBITDA margin 4.3%Q2 net income USD -28.364 millionoutlook FY adjusted EBITDA USD 120-135 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4167","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638068","title":"Evolent Health, - Raises 2026 Revenue Guidance to $2.6-$2.70 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638068?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVH","LU0053671581.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638053","title":"Evolent Health, - Expects 2027 Revenue Growth over 25% Compared to 2026 and Adj Ebitda Midpoint at or Above $150 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638053?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","LU0053671581.USD","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656255245","title":"Evolent Health, Inc. Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656255245","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656255245?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:39","pubTimestamp":1785854344,"startTime":"0","endTime":"0","summary":"Evolent Health, Inc. <EVH.N> expected to post a loss of2cents a share - Earnings PreviewEvolent Health, Inc.EVH.N,EVHis expected to  show a rise in quarterly revenue when it reports  results on August","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44124W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4167","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654025990","title":"Evolent Health price target lowered to $5 from $8 at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2654025990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654025990?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:36","pubTimestamp":1785242210,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Charles Rhyee lowered the firm’s price target on Evolent Health (EVH) to $5 from $8 and keeps a Buy rating on the shares ahead of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolent-health-price-target-lowered-to-5-from-8-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolent-health-price-target-lowered-to-5-from-8-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH","COWN","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654400681","title":"Evolent Health Inc : TD Cowen Cuts Target Price to $5 from $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2654400681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654400681?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:59","pubTimestamp":1785236367,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U0UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","EVH","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653172789","title":"Evolent Health Down over 14%, on Pace for Largest Percent Decrease Since November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2653172789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653172789?lang=en_us&edition=fundamental","pubTime":"2026-07-24 01:33","pubTimestamp":1784827980,"startTime":"0","endTime":"0","summary":"Evolent Health Inc Class A  is currently at $4.76, down $0.81 or 14.45%--Would be lowest close since June 22, 2026, when it closed at $4.48--On pace for largest percent decrease since Nov. 7, 2025,when it fell 17.33%--Currently down three consecutive days; down 19.65% over this period--Worst three day stretch since the three days ending Nov. 10, 2025, when it fell 22.05%--Down 12.08% month-to-date; on pace for worst month since March 2026, when it fell 29.85%--Up 19.12% year-to-date--Down 88.01% from its all-time closing high of $39.74 on Sept. 12, 2022--Down 49.04% from 52 weeks ago , when it closed at $9.35--Down 52.59% from its 52-week closing high of $10.05 on July 31, 2025--Up 119.59% from its 52-week closing low of $2.17 on March 30, 2026--Traded as low as $4.72; lowest intraday level since June 23, 2026, when it hit $4.43--Down 15.35% at today's intraday low; largest intraday percent decrease since Nov. 7, 2025, when it fell as much as 17.94%All data as of 1:30:09 PM ETSource: D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","EVH","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653742980","title":"Evolent Health Cut to Neutral from Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2653742980","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653742980?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:34","pubTimestamp":1784806440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVH/analyst-ratings(END) Dow Jones NewswiresJuly 23, 2026 07:34 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653889742","title":"Citigroup Downgrades Evolent Health to Neutral From Buy, Adjusts Price Target to $6.75 From $5.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2653889742","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653889742?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:26","pubTimestamp":1784806017,"startTime":"0","endTime":"0","summary":"Evolent Health (EVH) has an average rating of buy and mean price target of $5.96, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749910","title":"Evolent Health Inc : Citigroup Cuts to Neutral from Buy; Raises Target Price to $6.75 from $5.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653749910?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:33","pubTimestamp":1784802808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P0LL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVH","BK4167","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274248","title":"Evolent Health is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274248?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:32","pubTimestamp":1784633520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVH/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 07:32 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653727136","title":"Evolent Health price target raised to $7 from $6 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2653727136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653727136?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:56","pubTimestamp":1784631385,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Evolent Health (EVH) to $7 from $6 and keeps a Buy rating on the shares. The firm updated its model hea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolent-health-price-target-raised-to-7-from-6-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolent-health-price-target-raised-to-7-from-6-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651044633","title":"BTIG Remains a Buy on Evolent Health (EVH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651044633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651044633?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:55","pubTimestamp":1784199322,"startTime":"0","endTime":"0","summary":"In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Evolent Health, with a price target of $8.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-evolent-health-evh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-evolent-health-evh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH","LU0053671581.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evolent.com","stockEarnings":[{"period":"1week","weight":0.1289},{"period":"1month","weight":-0.3449},{"period":"3month","weight":-0.1411},{"period":"6month","weight":0.2596},{"period":"1year","weight":-0.6185},{"period":"ytd","weight":-0.1025}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.010716},{"month":2,"riseRate":0.727273,"avgChangeRate":0.019923},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.03999},{"month":4,"riseRate":0.818182,"avgChangeRate":0.120087},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.017156},{"month":6,"riseRate":0.727273,"avgChangeRate":0.085503},{"month":7,"riseRate":0.583333,"avgChangeRate":0.052186},{"month":8,"riseRate":0.666667,"avgChangeRate":0.042831},{"month":9,"riseRate":0.454545,"avgChangeRate":0.008116},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.131245},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.033571},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.029653}],"exchange":"NYSE","name":"Evolent Health","nameEN":"Evolent Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evolent Health(EVH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evolent Health,EVH,Evolent Health股票,Evolent Health股票老虎,Evolent Health股票老虎国际,Evolent Health行情,Evolent Health股票行情,Evolent Health股价,Evolent Health股市,Evolent Health股票价格,Evolent Health股票交易,Evolent Health股票购买,Evolent Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evolent Health(EVH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}